| Type | Title | Date Released | |
|---|---|---|---|
SCHEDULE 13D/A | LIGAND PHARMACEUTICALS INC (Filed by) | ||
425 | Form 425 | ||
425 | Form 425 | ||
8-K | Pelthos Therapeutics Enters Merger Agreement with Castle Creek Biosciences and $57.5 Million PIPE Financing | ||
4 | Greenleaf Peter (Reporting) | ||
4 | Friedberg Ezra M (Reporting) | ||
4 | Pauls Matthew (Reporting) | ||
8-K | Pelthos Therapeutics Announces Voting Results from 2026 Annual Meeting and Approval of New Equity Incentive Plan | ||
ARS | Form ARS | ||
DEFA14A | Form DEFA14A | ||
DEF 14A | Form DEF 14A | ||
10-Q | Form 10-Q |
